BUY Ajanta Pharma Limited — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)28 Oct 2024via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·11 Nov · 12mo ago
Nothing found in this tip’s window yet.
1 other SEBI-registered advisor has an active long-term SELL call on this stock
Advisor consensus · same horizon·31 Jan · 9mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Ajanta Pharma
- BUY — Manas Jaiswal23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY — Aastha Jain, Hem Securities30 Sept 2026 · Next day · target ₹3,800 · SL hit
- BUY — Sahi Research24 Sept 2026 · ~2 weeks · target ₹3,780 · SL hit
- BUY — Siddharth Rai Mangala18 Sept 2026 · ~2 weeks · target ₹3,770 · SL hit
- BUY — Kshitija Salvi, Globe Capital Market8 Sept 2026 · ~2 weeks · target ₹3,825 · SL hit
More from Motilal Oswal
- BUY Colgate Palmolive (India)22 Oct 2026 · ~1 year · target ₹2,000 · Active
- BUY Sapphire Foods India22 Oct 2026 · ~1 year · target ₹245 · Active
- BUY CIE Automotive India22 Oct 2026 · ~1 year · target ₹440 · Active
- BUY CREDITACCESS GRAMEEN22 Oct 2026 · ~1 year · target ₹1,450 · Active
- BUY KEI Industries22 Oct 2026 · ~1 year · target ₹5,180 · Active

